EXCLUSIVE: Services provider established by outsourcing giant Serco overcharged NHS by millions

 

Outsourcing giant Serco is embroiled in a fresh misuse of public funds scandal after a company it set up overcharged NHS hospitals millions of pounds, The Independent can reveal.

Internal documents leaked to Corporate Watch indicate Britain’s biggest pathology services provider, which was established by Serco in partnership with Guy’s and St Thomas’ hospitals, overcharged the NHS for diagnostic tests.

The venture - first called GSTS and now trading under the name Viapath - has also been dogged by allegations of cost-cutting and clinical failings.  Internal documents show increasing concern amongst senior consultants who claimed that staff cuts and a lack of investment since privatisation left some laboratories close to disaster. 

In internal emails clinicians said the company had an “inherent inability… to understand that you cannot cut corners and put cost saving above quality.” The trust and Viapath say the problems have now been resolved. But this only happened after the intervention of senior medical staff and changes to the structure of the joint venture that reduced Serco’s role.

A 2013 internal audit by the trust into three of the 15 laboratories run by Viapath found its invoicing and billing systems were “unreliable” and contained “material inaccuracies”, amounting to an overcharge of £283,561 over a sample three month period. The auditors found invoices included double-counting of tests charged to the hospitals, with both samples and patients included in bills, and that the Trust had been “indirectly providing a free pathology service” to other NHS bodies by being billed for outside work done. They estimated this could represent approximately £1 million in 2012 alone.

The full scale of the over-charging is not known because a full audit has never been conducted.

But The Independent has also seen documents highlighting concerns raised by senior NHS managers over the accuracy of billing from other laboratories. One department raised a dispute over £1 million in 2011 due to what they said were errors including the suggestion that two different labs were charged for the same tests.

Margaret Hodge, chair of the Public Accounts Committee said: “After a series of high profile failures, Government claims it has a grip on contracts with private companies to deliver our public services. Clearly it hasn’t. This is not just about ripping off the taxpayer, but about a failure to provide acceptable quality in a service that is vital for diagnosing what it many cases are serious or even life-threatening illnesses.

“It is also not the first time that serious concerns have been raised about Serco and its track record, including in other parts of the NHS where last year our Committee reported on substandard service and data manipulation in a contract to provide GP out-of-hours services.”

Chair of the Commons Public Accounts Committee, Margaret Hodge Chair of the Commons Public Accounts Committee, Margaret Hodge (Getty)
Pathology laboratories are central to the NHS, with blood and tissue analysis used in 70 per cent of all patient diagnoses. Viapath – a joint venture between Serco and Guy's and St Thomas’ hospital trust and King’s College hospital – is the largest pathology service provider in the UK, processing more than 22 million tests a year in London and Bedford.

Viapath declared it would combine the hospitals’ “clinical and scientific excellence” with the “service and business excellence” of outsourcing giant Serco when it was founded in 2009.

The joint venture was supposed to have reformed the Trust's commercial practices in the early stages of the contract, signed in 2009. However, a promised reform of charging has still not been introduced.

Serco had a controlling, 51 per cent voting share in the partnership, which made a £3.8 million profit last year. However after several failings the hospitals renegotiated the contract to an equal three-way split in 2012.

In a review of its first four years, marked “strictly confidential”, CEO Richard Jones admitted that it had “achieved much less than hoped” and that “initial attempts at transformation were badly handled and ended up costing money rather than saving it”.

An NHS commercial manager close to the contract told the Independent: “When you’re taking over a contract of this complexity it’s unreasonable to expect to fix the problem on day one. But the contract was set up on the basis that they had a year to turn things around and get things in proper shape. When they were unable to do it the trust should have ended the contract.”

They added: “They haven’t improved efficiency. Going into a service like this and making it more efficient and ensuring that people are billed properly - that’s where you think the private sector will add value. Serco know the public sector behaves this way and they take advantage. They use the ambiguity and inefficiency of the public sector that they’re meant to be improving on to take advantage of that inherited incompetence.”

Senior consultants have raised concerns over the effects of the “financial squeeze” by Viapath on some Guy's and St Thomas' labs. In June last year senior clinicians in the histopathology laboratory – which tests tissue samples for disease - made a complaint to Viapath. They claimed that their policy “over the last three years of either not replacing leavers or downgrading them has left us with a department that cannot cope with the technical complexity of our workload. This is now resulting in errors, poor turnaround times and now, an inability to perform quality control” for gynaecologic tests.

Auditors found double-counting of lab tests and that Guy’s and St Thomas’ had been indirectly providing a free pathology service to other bodies Auditors found double-counting of lab tests and that Guy’s and St Thomas’ had been indirectly providing a free pathology service to other bodies (Alamy)
Consequences alleged included delays in scanning for the HPV virus, too few staff to book in samples for processing and quality control checks for semen analysis not being done.

A Clinical Director at the hospitals described it as “yet another lab in distress and part of a recurring pattern.” In a document written in August 2013 entitled “[Viapath]: the Great Leap Backwards”, Professor Tony Wierzbicki, the clinical lead for Blood Sciences said Viapath has not made the necessary investment into one of the “very few departments in the hospital whose failure can cause the whole institution to close”.

The review accused Viapath of ignoring consultants' concerns, “inadequate” investment and haemorrhaging experienced staff by introducing “a large pay cut with no improvement in working conditions”. It claimed disaster was avoided “only just” in 2013, and that the rate of “near miss 'never' events has climbed dramatically”, with new chemistry analysers brought in by Viapath apparently unable to read barcodes on a quarter of specimens and too slow to cope with peak demand compounding staff shortages.

The clinician also claimed that “minor events are often not recorded as the culture of [Viapath] means staff know the practical consequences of honesty.”

The service previously came under fire after it emerged that more than 400 clinical “incidents” had happened with its tests in 2011 – including losing or mislabelling patients’ blood and cell samples. Its first year performance review by the hospital's management said there appeared to be an increase in the number of these incidents since Viapath became involved.

Further mistakes in 2012 included a patient given the wrong blood after the system did not flag their medical history - and a patient’s kidney damage results showing up incorrectly after a “software fault”.

In a statement sent to The Independent by the trust’s press office, Professor Wierzbicki said: “I raised concerns 12 months ago during the internal review process. My concerns at that time have been resolved and there has been significant investment in staff and equipment. This has led to shorter waiting times for blood tests and a quicker turnaround time of services to key departments such as A&E.”

Guy’s and St Thomas’ Trust said in a statement that a September 2013 internal review commissioned by the Trust’s Audit Committee, including interviews with Viapath staff and frontline clinicians, concluded that: “notwithstanding some early challenges during the first years of Viapath, the new management team at Viapath was making good progress in transforming pathology services in terms of quality and value for money.”

The Trust said “there are no disputed invoices between Guy’s and St Thomas’ and Viapath. Billing arrangements are governed by a contract which is monitored regularly with data shared in an open and transparent way. If activity data errors or anomalies are identified, these are resolved on a case by case basis at monthly finance meetings and adjustments are made to subsequent invoices. Such adjustments have amounted to only 0.4 per cent of the cumulative contract value over the last five years.”

Richard Jones, Viapath chief executive, said he welcomed the trust’s statement and added: “Viapath had a difficult start but the partners have worked together to deliver ongoing improvements in service delivery and investment in innovation which is now yielding benefits for patients and our many NHS users. Our scientists and clinicians are world class and I am proud of the service we are delivering for the NHS.”

A Department of Health spokesman said: “All providers of services to NHS patients, whether independent or NHS healthcare providers, are required to meet the same high standards on both patient care and strong financial control. The responsibility for holding accountable any company or provider which breaches conditions of its contract lies with the relevant NHS commissioning body.”

Serco: a history in scandals

Serco earns over £1 billion from its public sector contracts every year but it has been hit by a series of scandals over the past two years.

It is currently under investigation by the Serious Fraud Office for overcharging the Government for the electronic tagging of offenders, some of whom were found to be dead, back in prison or overseas. Serco agreed to repay the government £68.5m at the end of last year.

Last year the company agreed to the early termination of its contract for out-of-hours GP services in Cornwall after falsifying performance data, failing to meet national standards and having a ‘bullying’ culture.

The Serco-run prison, HMP Doncaster, came under heavy criticism from the prison inspectorate last year after it emerged it had locked up inmates in cells without water or electricity for more than two days.

News
Russell Brand was in typically combative form during his promotional interview with Newsnight's Evan Davis
peopleReports that Brand could stand for Mayor on an 'anti-politics' ticket
News
The clocks go forward an hour at 1am on Sunday 30 March
news
Arts and Entertainment
The Doctor finds himself in a forest version of London in Doctor Who episode 'In the Forest of the Night'
TVReview: Is the Doctor ever going stop frowning? Apparently not.
News
Voluminous silk drawers were worn by Queen Victoria
newsThe silk underwear is part of a growing trade in celebrity smalls
PROMOTED VIDEO
Have you tried new the Independent Digital Edition apps?
News
ebooksAn unforgettable anthology of contemporary reportage
Sport
footballMatch report: Real fight back to ruin Argentinian's debut
News
Candidates with surnames that start with an A have an electoral advantage
newsVoters are biased towards names with letters near start of alphabet
Arts and Entertainment
Isis with Lord Grantham (Hugh Bonneville)
TV
Arts and Entertainment
Jay James
TVReview: Performances were stale and cheesier than a chunk of Blue Stilton left out for a month
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Maths Teacher

£110 - £200 per day: Randstad Education Leeds: Secondary Maths Teacher for spe...

Business Analyst - Surrey - Permanent - Up to £50k DOE

£40000 - £50000 Per Annum Excellent benefits: Clearwater People Solutions Ltd:...

***ASP.NET Developer - Cheshire - £35k - Permanent***

£30000 - £35000 Per Annum Excellent benefits: Clearwater People Solutions Ltd:...

***Solutions Architect*** - Brighton - £40k - Permanent

£35000 - £40000 Per Annum Excellent benefits: Clearwater People Solutions Ltd:...

Day In a Page

Wilko Johnson, now the bad news: musician splits with manager after police investigate assault claims

Wilko Johnson, now the bad news

Former Dr Feelgood splits with manager after police investigate assault claims
Mark Udall: The Democrat Senator with a fight on his hands ahead of the US midterm elections

Mark Udall: The Democrat Senator with a fight on his hands

The Senator for Colorado is for gay rights, for abortion rights – and in the Republicans’ sights as they threaten to take control of the Senate next month
New discoveries show more contact between far-flung prehistoric humans than had been thought

New discoveries show more contact between far-flung prehistoric humans than had been thought

Evidence found of contact between Easter Islanders and South America
Cerys Matthews reveals how her uncle taped 150 interviews for a biography of Dylan Thomas

Cerys Matthews on Dylan Thomas

The singer reveals how her uncle taped 150 interviews for a biography of the famous Welsh poet
DIY is not fun and we've finally realised this as a nation

Homebase closures: 'DIY is not fun'

Homebase has announced the closure of one in four of its stores. Nick Harding, who never did know his awl from his elbow, is glad to see the back of DIY
The Battle of the Five Armies: Air New Zealand releases new Hobbit-inspired in-flight video

Air New Zealand's wizard in-flight video

The airline has released a new Hobbit-inspired clip dubbed "The most epic safety video ever made"
Pumpkin spice is the flavour of the month - but can you stomach the sweetness?

Pumpkin spice is the flavour of the month

The combination of cinnamon, clove, nutmeg (and no actual pumpkin), now flavours everything from lattes to cream cheese in the US
11 best sonic skincare brushes

11 best sonic skincare brushes

Forget the flannel - take skincare to the next level by using your favourite cleanser with a sonic facial brush
Paul Scholes column: I'm not worried about Manchester United's defence - Chelsea test can be the making of Phil Jones and Marcos Rojo

Paul Scholes column

I'm not worried about Manchester United's defence - Chelsea test can be the making of Jones and Rojo
Frank Warren: Boxing has its problems but in all my time I've never seen a crooked fight

Frank Warren: Boxing has its problems but in all my time I've never seen a crooked fight

While other sports are stalked by corruption, we are an easy target for the critics
Jamie Roberts exclusive interview: 'I'm a man of my word – I'll stay in Paris'

Jamie Roberts: 'I'm a man of my word – I'll stay in Paris'

Wales centre says he’s not coming home but is looking to establish himself at Racing Métro
How could three tourists have been battered within an inch of their lives by a burglar in a plush London hotel?

A crime that reveals London's dark heart

How could three tourists have been battered within an inch of their lives by a burglar in a plush London hotel?